Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Concert Pharmaceuticals initiates phase II trial of CTP-543 in alopecia areata

May 3, 2017

Almirall discovers TRPA1 antagonists

May 2, 2017

Almirall discloses new TRPA1 antagonists

April 26, 2017

Filgotinib begins new phase II trial in cutaneous lupus erythematosus

April 26, 2017

AbbVie seeks Japanese approval for Humira in pustular psoriasis

April 26, 2017

EMA committee recommends approval of Skilarence for psoriasis

April 25, 2017

Japanese approval sought for guselkumab

April 21, 2017

BioCryst Pharmaceuticals presents plasma kallikrein inhibitors

April 20, 2017

Phase I/IIa trial of FOL-005 demonstrates stimulation of hair growth in healthy volunteers

April 20, 2017

ADX-102 granted U.S. orphan status for congenital ichthyosis

April 19, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...